DeepMed Research

Wuerzburg University Hospital

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Cognitive Ability Training in Seniors

Not Applicable

Completed

Conditions: Mild Cognitive Impairment

Interventions: Device: Sham tDCS
Device: Verum tDCS

First Posted Date: 2015-10-27

Last Posted Date: 2024-03-12

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 38

Registration Number: NCT02587338

Locations: 🇩🇪
University hospital, Wuerzburg, Germany

Volume Therapy With Crystalloids and Colloids and Hemodynamic Monitoring in Patients With Severe Sepsis

Phase 4

Withdrawn

Conditions: Severe Sepsis

Interventions: Drug: Volulyte
Drug: Jonosteril

First Posted Date: 2015-10-27

Last Posted Date: 2016-11-30

Lead Sponsor: Wuerzburg University Hospital

Registration Number: NCT02587078

Prevention of Postoperative Acute Kidney Injury

Not Applicable

Withdrawn

Conditions: Acute Kidney Injury

Interventions: Procedure: kidney treatment bundle (KDIGO)

First Posted Date: 2015-10-22

Last Posted Date: 2018-06-01

Lead Sponsor: Wuerzburg University Hospital

Registration Number: NCT02583945

Locations: 🇩🇪
University Hospital Wuerzburg, Dep. of Anesthesiology, Wuerzburg, Germany

Perioperative Change of Regional Ventilation During Spontaneous Breathing

Completed

Conditions: Pulmonary Infection
Pleural Effusion
Aspiration Pneumonitis
Atelectasis
Pneumothorax
Bronchospasm
Respiratory Insufficiency

Interventions: Other: Perioperative pulmonary function tests

First Posted Date: 2015-04-17

Last Posted Date: 2016-03-01

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 72

Registration Number: NCT02419196

Locations: 🇩🇪
University of Würzburg, Würzburg, Germany

Burden of Disease in Hypophosphatasia (HPP)

Completed

Conditions: Hypophosphatasia

First Posted Date: 2014-11-14

Last Posted Date: 2016-11-08

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 114

Registration Number: NCT02291497

Locations: 🇩🇪
Clinical Trial Unit, Orthopaedische Klinik Koenig-Ludwig-Haus, Lehrstuhl der Universitaet Wuerzburg, Wuerzburg, Bavaria, Germany

TMS Augmented Exposure Therapy

Not Applicable

Completed

Conditions: Phobia

First Posted Date: 2014-08-22

Last Posted Date: 2023-08-02

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 47

Registration Number: NCT02223767

Locations: 🇩🇪
University hospital, Wuerzburg, Germany

Combined FDG-PET and 123I-Iodometomidate Imaging for Adrenal Neoplasia

Phase 3

Conditions: Adrenal Gland Neoplasms

Interventions: Other: FDG positron emission tomography
Other: Iodometomidate imaging

First Posted Date: 2013-12-13

Last Posted Date: 2018-04-11

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 220

Registration Number: NCT02010957

Locations: 🇩🇪
University Hospital Wuerzburg, Wuerzburg, Germany

Hypercapnia to Prevent Secondary Ischemia in SAH

Phase 1

Completed

Conditions: Aneurysmal Subarachnoid Hemorrhage

Interventions: Procedure: Hypercapnia by reduction of respiratory volume

First Posted Date: 2013-02-26

Last Posted Date: 2014-12-10

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 10

Registration Number: NCT01799525

Locations: 🇩🇪
Department of Neurosurgery, University of Wuerzburg, Wuerzburg, Bavaria, Germany

Effects of a Partially Supervised Conditioning Program in CF

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Behavioral: Exercise Intervention

First Posted Date: 2012-12-06

Last Posted Date: 2018-10-22

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 155

Registration Number: NCT01744561

Locations: 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇫🇷
Hôpital Maison Blanche, Service : Maladies respiratoires, Reims, France

and more 25 locations

Mineralocorticoid Receptor Antagonists in End Stage Renal Disease

Phase 2

Completed

Conditions: End Stage Renal Disease / Hemodialysis

Interventions: Drug: Placebo
Drug: Spironolactone

First Posted Date: 2012-09-24

Last Posted Date: 2019-08-06

Lead Sponsor: Wuerzburg University Hospital

Target Recruit Count: 118

Registration Number: NCT01691053

Locations: 🇩🇪
University Hospital Erlangen-Nürnberg, Erlangen, Germany
🇩🇪
University Hospital Frankfurt, Frankfurt, Germany
🇩🇪
University Hospital Wuerzburg, Wuerzburg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy